FDA releases guidance on advisory panel disclosure

04/6/2014 | MassDevice.com (Boston)

The FDA has issued guidelines for participation on advisory panels for new drugs and devices. The guidelines require that prospective advisers disclose business relationships and permit the FDA to accept a consultant on a panel despite possible conflicts of interest.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA